OS Therapies Inc. Form 8-K Summary
Business Context and Reporting Period
OS Therapies Incorporated (OSTX), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on September 10, 2026. The filing relates to a prospectus supplement filed under the Company's effective Form S-3 registration statement (File No. 333-289443).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a legal and regulatory event rather than financial performance.
Material Changes and Events
- Resale Registration: The Company filed a prospectus supplement covering the resale of up to 5,874,094 shares of common stock by selling stockholders.
- Legal Opinion: The primary purpose of this 8-K is to provide the legal opinion of counsel, Olshan Frome Wolosky LLP, regarding the legality of the shares being resold.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on operations, specific risks, or contingencies beyond the standard disclosure of the resale transaction.
Investor Verification Checklist
- Verify the identity of the selling stockholders referenced in the attached Prospectus Supplement.
- Review the full text of the legal opinion (Exhibit 5.1) to confirm the legality of the share resale.
- Check the Company's Form S-3 (File No. 333-289443) for the broader context of the registration statement.